Related Experiment Video
Updated: Jan 26, 2026

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy
Published on: December 30, 2025
Expression of Gstt1 in Type 2 Diabetic Retinopathy Patients
Saima Sharif1, Maha Maqsood1, Shagufta Naz1
1Department of Zoology, Lahore College for Women University, Lahore, Pakistan.
Abstract:
Type 2 diabetes mellitus (T2DM) is the most common metabolic and multifactorial disease in which both genetic and environmental factors are involved. In diabetes, the defects in the cellular metabolism result in higher levels of free radicals. These radicals react with other vital cellular molecules, which are responsible in diabetes side effects and known as diabetic retinopathy (DR), a disease of the retina that results in impairment or loss of vision. In the present study, we investigated the expression of glutathione S-transferases class theta 1 (GSTT1) in type 2 DR subjects. Highly significant differences (P ≤ 0.05) were observed in GSST1 expression in DR patients compared with diabetic and control groups.
Insights
This study found significant differences in glutathione S-transferases class theta 1 (GSTT1) expression in patients with type 2 diabetes and vision-impairing diabetic retinopathy (DR). Understanding GSTT1 may offer insights into diabetes complications.
Area of Science:
- Biochemistry
- Ophthalmology
- Genetics
Background:
- Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder influenced by genetic and environmental factors.
- Metabolic defects in diabetes lead to increased free radicals, causing cellular damage and complications like diabetic retinopathy (DR).
- Diabetic retinopathy (DR) is a leading cause of vision impairment and blindness in diabetic patients.
Purpose of the Study:
- To investigate the expression levels of glutathione S-transferases class theta 1 (GSTT1) in individuals with type 2 diabetes and DR.
- To compare GSTT1 expression between DR patients, diabetic patients without DR, and healthy controls.
Main Methods:
- The study involved comparing GSTT1 gene expression across three groups: patients with type 2 diabetes and DR, patients with type 2 diabetes but without DR, and a control group.
- Statistical analysis was performed to determine the significance of observed differences in GSTT1 expression.
Main Results:
- Highly significant differences (P ≤ 0.05) in GSTT1 expression were observed in DR patients compared to both diabetic and control groups.
- The findings suggest a potential role for GSTT1 in the pathogenesis of diabetic retinopathy.
Conclusions:
- GSTT1 expression is significantly altered in patients with type 2 diabetes and diabetic retinopathy.
- Further research into GSTT1 may elucidate its role in the development and progression of DR, potentially leading to new therapeutic targets.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer
Types of Hormones

